Clinical Trials Logo

Clear Cell Ependymoma clinical trials

View clinical trials related to Clear Cell Ependymoma.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02722512 Terminated - Clinical trials for Glioblastoma Multiforme

Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine

Start date: July 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine whether Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine is an feasible and safe treatment for pediatric patients with newly-diagnosed High-Grade Gliomas or recurrent, resectable High-Grade Gliomas and Ependymomas.